MARKET NEWS

Biologics Patent Expiry Trend Expected to Have Positive Impact
Stevanato Group & Bormioli Pharma Sign Collaboration Agreement
Synteract Expands Into Asia Pacific & South Africa Through Acquisition of Specialty Biometrics CRO
CURE Pharmaceutical Signs Exclusive Licensing Agreement With ReLeaf Europe 
AskBio Announces First Patient Dosed in Phase 1 Trial
Cellectricon & StressMarq Biosciences Collaborate to Develop Next-Generation Reagents & Assays

  FEATURED EDITORIAL

  COMPANY PROFILE

Experts in subcutaneous drug delivery systems for self-administration, Haselmeier provides innovative and award-winning individual system solutions to support patients for a successful therapy. This family-owned business covers all steps – from design to planning to industrialization – in the creation of high-quality self-injection systems. In 2020, this well-established company will be able to look back on a 100-year-old success story. Click here for more.

  EXCLUSIVE ONLINE CONTENT

PharmaCyte Biotech Will Have All the Protection It Needs Upon Marketing Approval

PharmaCyte Biotech Will Have All the Protection It Needs Upon Marketing Approval

PharmaCyte Biotech recently announced it is about to embark upon a planned US FDA Phase 2b clinical trial to treat locally advanced, inoperable pancreatic cancer (LAPC) at trial sites all over the US, and with that journey comes the….

Two Labs Acquires CEEK Enterprises

Two Labs Acquires CEEK Enterprises

Two Labs recently announced it has acquired CEEK Enterprises, a management consultancy dedicated to supporting clients in the biopharma and MedTech industries with specialized expertise in….

Pelican BioThermal Announces the Acquisition of NanoCool 

Pelican BioThermal Announces the Acquisition of NanoCool 

Pelican BioThermal recently announced the acquisition of NanoCool, an Albuquerque, New Mexico-based manufacturer of temperature-controlled packaging solutions. This acquisition further…..

Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global

Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global

Catalent, Inc. recently announced it has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc. for an aggregate of…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 22 – Drug Delivery
February 29 – Bioavailability